ORIC Prakiraan wutah bathi resik saben saham kanggo taun ngarep oricpharma.com

Logo korporat perusahaan ORIC Corp (ORIC)

The consensus EPS n+1 forecast chart reinforces the status of ORIC Pharmaceuticals (ORIC) as an innovator in targeted therapy combating molecular tumor resistance. Stable management with deep oncology expertise ensures strict adherence to trial timelines. The value of -11.20 indicates current expectation levels, which are supported by the partnership with Pfizer, the progress of ORIC-114 and ORIC-944, and a significant liquidity position.

ORIC: Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep ORIC Pharmaceuticals Inc 04.07.2022 - 10.11.2026

Rincian metrik keuangan lan pasar oricpharma.com (ORIC)

- rega saham lan konsensus proyeksi valuasi:
Rega saham ORIC Pharma|ORIC - Prakiraan konsensus analis
- data kapitalisasi pasar:
Nilai pasar ORIC Pharmaceuticals|ORIC - Nilai Dipunlarasaken Utang lan Kas
- rincian nilai buku perusahaan:
Nilai Buku saben Saham ORIC Pharmaceuticals|ORIC - Nilai Buku Bisnis|Rasio Kapitalisasi Pasar marang Nilai Buku oricpharma.com|ORIC - Aset Perusahaan
- indikator total utang lan likuiditas perusahaan:
Rasio Total Utang marang Ekuitas ORIC Pharmaceuticals|ORIC - Rasio silihan jangka dawa marang modal|Utang jangka cendhak marang modal ORIC Pharmaceuticals, Inc.|ORIC - Utang kumulatif perusahaan|Utang-utang marang kapitalisasi buku ORIC Pharmaceuticals|ORIC - Tanggungan utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan ORIC Pharmaceuticals|Indikator likuiditas cepet oricpharma.com
- informasi bathi lan kelipatan valuasi:
ORIC - Bathi sawise mbayar pajeg|Proyeksi bathi mangsa ngarep ORIC Pharmaceuticals|ORIC - Nilai perusahaan marang bathi resik|Pangali Forward P/E ORIC Pharmaceuticals|ORIC - Rega marang bathi kanthi panyesuaian wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan ORIC Pharmaceuticals|ORIC - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi resik saben saham (EPS TTM) ORIC Pharmaceuticals|ORIC - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan oricpharma.com|ORIC - Dinamika bathi saben saham ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep ORIC Pharmaceuticals
Analisis fundamental perusahaan:ORIC Pharma, ORIC
Produk merek oricpharma.com

Professional capital evaluates ORIC Pharmaceuticals (ORIC) through the lens of targeted therapy commercialization, where expansion rates within the tumor resistance segment determine the future business value. Analyzing the projected EPS growth for the coming year on GURU.Markets, an investor can see the trend of revised earnings expectations; however, a sharp spike in this metric signals rising speculative risks and a decline in the asset's overall stability.

Perusahaan pesaing

GMAB (Genmab US) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep Exelixis Inc.|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Nuvalent, Inc. (NUVL)|KYMR (kymeratx.com) - Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi kanggo taun ngarep IDYA (IDEAYA Biosciences, Inc.)|Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep Enliven Therapeutics Inc|Relay Pharma - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Nurix Corp|TYRA (Tyra Biosciences, Inc.) - Prakiraan wutah bathi saben saham kanggo taun ngarep|VSTM: Proyeksi tambahing bathi saben saham ing taun ngarep|GLUE (Monte Rosa Therapeutics, Inc.) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Cullinan Oncology CGEM|Prakiraan wutah bathi kanggo taun ngarep IMRX|C4 Therapeutics Corp - Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep|Black Diamond - Prakiraan wutah bathi saben saham kanggo taun ngarep|Dinamika bathi saben saham sing diarepake ing taun ngarep RPTX|PMVP: Prakiraan wutah bathi saben saham kanggo taun ngarep|Karyopharm Therapeutics - Proyeksi tambahing bathi saben saham ing taun ngarep|PPCB: Prakiraan wutah bathi kanggo taun ngarep|Cyclacel - Dinamika bathi saben saham sing diarepake ing taun ngarep|AADI (Aadi Bioscience Inc) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Aileron ALRN|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Blueprint Medicines (BPMC)|GLYC (glycomimetics.com) - Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi kanggo taun ngarep SWTX (SpringWorks)